These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10459745)

  • 21. Interferon-induced anosmia in a patient with chronic hepatitis C.
    Maruyama S; Hirayama C; Kadowaki Y; Sagayama A; Omura H; Nakamoto M
    Am J Gastroenterol; 1998 Jan; 93(1):122-3. PubMed ID: 9448193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response.
    Espinosa M; Rodriguez M; Martin-Malo A; Alvarez de Lara MA; Gonzalez R; Lopez-Rubio F; de la Mata M; Aljama P
    Clin Nephrol; 2001 Mar; 55(3):220-6. PubMed ID: 11316242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature].
    Téllez-Zenteno JF; Negrete-Pulido O; Nuñez M; Estañol-Vidal B; García-Ramos G
    Rev Neurol; 2002 Oct 1-15; 35(7):644-6. PubMed ID: 12389150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mononeuropathy multiplex in a patient receiving interferon alpha therapy for chronic hepatitis C].
    Maeda M; Ohkoshi N; Hisahara S; Mizusawa H; Shoji S
    Rinsho Shinkeigaku; 1995 Sep; 35(9):1048-50. PubMed ID: 8565346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in glucose tolerance after interferon-alpha therapy in patients with chronic hepatitis C.
    Tanaka H; Shiota G; Kawasaki H
    J Med; 1997; 28(5-6):335-46. PubMed ID: 9604792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychosis in a methadone-substituted patient during interferon-alpha treatment of hepatitis C.
    Schäfer M; Boetsch T; Laakmann G
    Addiction; 2000 Jul; 95(7):1101-4. PubMed ID: 10962774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major depressive disorder with psychotic features induced by interferon-alpha treatment for hepatitis C in a polydrug abuser.
    Kalyoncu OA; Tan D; Mirsal H; Pektas O; Beyazyurek M
    J Psychopharmacol; 2005 Jan; 19(1):102-5. PubMed ID: 15671136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thyrotoxicosis due to long-term therapy with interferon alpha in the patient with mixed chronic active hepatitis B and C].
    Vortel J; Bures J; Rejchrt S; Zivný P; Palicka V
    Vnitr Lek; 1999 May; 45(5):301-4. PubMed ID: 15641255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
    Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
    Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of high-dose interferon in the treatment of chronic hepatitis C.
    Shiffman ML
    Semin Liver Dis; 1999; 19 Suppl 1():25-33. PubMed ID: 10349690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychiatric manifestations accompanying interferon therapy for patients with chronic hepatitis C: an overview of cases in Japan.
    Nozaki O; Takagi C; Takaoka K; Takata T; Yoshida M
    Psychiatry Clin Neurosci; 1997 Aug; 51(4):175-80. PubMed ID: 9316160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Five cases of interferon-alpha-induced depression treated with antidepressant therapy.
    Gleason OC; Yates WR
    Psychosomatics; 1999; 40(6):510-2. PubMed ID: 10581980
    [No Abstract]   [Full Text] [Related]  

  • 34. [How safe are dimenhydrinate suppositories?].
    Bernhard MK; Mütze U; Syrbe S
    Dtsch Med Wochenschr; 2013 Oct; 138(42):2143-5. PubMed ID: 24104589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Onset of generalized seizures after intrathecal interferon therapy of SSPE.
    Caksen H; Odabaş D; Anlar O; Ataş B; Tuncer O
    Pediatr Neurol; 2003 Jul; 29(1):78-9. PubMed ID: 13679130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epileptic seizure in GHB withdrawal.
    Chew G; Fernando A
    Australas Psychiatry; 2004 Dec; 12(4):410-1. PubMed ID: 15715821
    [No Abstract]   [Full Text] [Related]  

  • 37. Complications of baclofen withdrawal.
    Terrence CF; Fromm GH
    Arch Neurol; 1981 Sep; 38(9):588-9. PubMed ID: 6791618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of γ-butyrolactone associated with severe withdrawal delirium and acute renal failure.
    Bhattacharya IS; Watson F; Bruce M
    Eur Addict Res; 2011; 17(4):169-71. PubMed ID: 21454980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxazepam withdrawal syndrome.
    Dobbie JA
    Med J Aust; 1982 Jun; 1(13):545. PubMed ID: 6810073
    [No Abstract]   [Full Text] [Related]  

  • 40. Correlation between quantitative-EEG alterations and age in patients with interferon-alpha-treated hepatitis C.
    Kamei S; Oga K; Matsuura M; Tanaka N; Kojima T; Arakawa Y; Matsukawa Y; Mizutani T; Sakai T; Ohkubo H; Matsumura H; Moriyama M; Hirayanagi K
    J Clin Neurophysiol; 2005; 22(1):49-52. PubMed ID: 15689713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.